A new study published in PLOS Medicine suggests people prescribed a single-pill fixed-dose drug combination (FDC) to manage hypertension are more likely to be compliant with their medication and achieve better health outcomes than those taking separate pills.

The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.

Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. A new therapy could reduce the need for operations, the U.K.’s Express newspaper reports, with researchers hoping the therapy could save lives while being cost effective. 

Patients who utilize a healthy lifestyle smartphone application may be able to slow arterial aging, according to results from the EVIDENT II trial presented at EuroHeartCare 2018 in Dublin.

Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.

Measurements of malnutrition offer incremental prognostic value for patients with heart failure, but more work is needed to tease out which components of the condition are most crucial to calculate and treat, researchers reported in JACC: Heart Failure.

Minorities, specifically blacks and Hispanics, are more than twice as likely to have a second intracerebral hemorrhage than white counterparts, according to a new study published in Neurology on June 6.

The introduction of high-sensitivity cardiac troponin T (hs-cTnT) in Sweden was associated with an 11 percent reduction in reinfarctions among heart attack patients and increased use of coronary angiography and revascularization, according to a study published June 4 in the Journal of the American College of Cardiology.